De Novo Tumors Are a Major Cause of Late Mortality After Orthotopic Liver Transplantation

Transplantation Proceedings

Volumn 41, Issue 4, 2009, Pages 1303-1305

  Baccarani, U ^a   Adani, G L ^a   Serraino, D ^b   Lorenzin, D ^a   Gambato, M ^c   Buda, A ^c   Zanus, G ^c   Vitale, A ^c   Piselli, P ^d   De Paoli, A ^b   Bresadola, V ^a   Risaliti, A ^e   Toniutto, P ^a   Cillo, U ^c   Bresadola, F ^a   Burra, P ^c  

^a UNIVERSITY HOSPITAL OF UDINE   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^e UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST TUMOR; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CANCER SURVIVAL; CAUSE OF DEATH; COLON CANCER; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; ESOPHAGUS TUMOR; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HIGH RISK POPULATION; HUMAN; KAPOSI SARCOMA; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; MORTALITY; NONHODGKIN LYMPHOMA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; STANDARDIZED INCIDENCE RATIO; STOMACH ADENOCARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TIME SERIES ANALYSIS; UTERINE CERVIX CANCER; NEOPLASMS;

HUMANS; LIVER TRANSPLANTATION; NEOPLASMS; SURVIVAL RATE;

EID: 65549149433     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.03.079     Document Type: Article

References (10)

1. Haagsma E.B., Hagens V.E., Schaapveld M., et al. Increased cancer risk after liver transplantation: a population-based study. J Hepatol 34 (2001) 84
2. Buell J.F., Gross T.G., and Woodle E.S. Malignancy after transplantation. Transplantation 80 (2005) S254
3. Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. In: Cecka J.M., and Terasaki P.I. (Eds). Clinical Transplant 1998 (1998), UCLA Tissue Typing Laboratory, Los Angeles, Calif 147
4. In: Parkin D.M., Whelan S.L., Ferlay J., et al. (Eds). Cancer Incidence in Five Continents, Vol VII. IARC Scientific Publications No. 143 (1997), IARC Press, Lyon
5. Haagsma E.B., Hagens V.E., Schaapveld M., et al. Increased cancer risk after liver transplantation: a population-based study. J Hepatol 34 (2001) 84
6. Oo Y.H., Gunson B.K., Lancashire R.J., et al. Incidence of cancers following orthotopic liver transplantation in a single center: comparison with national cancer incidence rates for England and Wales. Transplantation 80 (2005) 759
7. Sanchez E.Q., Marubashi S., Jung G., et al. De novo tumors after liver transplantation: a single-institution experience. Liver Transpl 8 (2002) 285
8. Jain A.B., Yee L.D., Nalesnik M.A., et al. Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation 66 (1998) 1193
9. Frezza E.E., Fung J.J., and van Thiel D.H. Non-lymphoid cancer after liver transplantation. Hepatogastroenterology 44 (1997) 1172
10. Benlloch S., Berenguer M., Prieto M., et al. De novo internal neoplasms after liver transplantation: increased risk and aggressive behavior in recent years?. Am J Transplant 4 (2004) 596